ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,453Medicare Part D Prescriptions Filled, Including Refills

Rank: 458 out of 939

$306K Total Retail Price of All Prescriptions

Rank: 461 out of 939

311 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 311 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 311 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 4,230 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
GABAPENTIN 208 121 1 11
HYDROCODONE-ACETAMINOPHEN 204 106 S3 2 1
LISINOPRIL 204 126 2 3
PRAVASTATIN SODIUM 177 94 4 13
FUROSEMIDE 170 151 5 7
OMEPRAZOLE 168 112 6 5
AMLODIPINE BESYLATE 162 106 7 6
METFORMIN HCL 149 54 8 8
CITALOPRAM HBR 135 102 9 15
LEVOTHYROXINE SODIUM 133 88 10 4
POTASSIUM CHLORIDE 118 116 11 9
SIMVASTATIN 112 93 12 2
WARFARIN SODIUM 92 85 13 17
ATENOLOL 91 51 14 19
SERTRALINE HCL 84 51 15 24
CARVEDILOL 83 83 16 25
TRAMADOL HCL 74 46 17 16
DONEPEZIL HCL 72 72 18 30
PREDNISONE 72 58 18 42
CEFUROXIME 67 46 20 166
NEXIUM 66 42 21 18
METOPROLOL SUCCINATE 64 44 22 21
HYDROCHLOROTHIAZIDE 62 50 23 12
DOXAZOSIN MESYLATE 62 37 23 108
CRESTOR 61 44 25 34
AMITRIPTYLINE HCL 60 48 R 26 38
ZOLPIDEM TARTRATE 58 31 27 20
CLOPIDOGREL 57 46 28 28
GLIPIZIDE 57 38 28 52
LOSARTAN POTASSIUM 56 40 30 29
VENTOLIN HFA 56 42 30 80
AZITHROMYCIN 56 33 30 32
PROMETHAZINE HCL 55 22 R 33 68
FENTANYL 54 47 S2 34 104
VENLAFAXINE HCL 53 0 35 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.